Trials / Conditions / Multiple Sclerosis, Chronic Progressive

Multiple Sclerosis, Chronic Progressive

19 registered clinical trials studyying Multiple Sclerosis, Chronic Progressive — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Clinnova-MS: A Prospective Cohort Study of Patients With Multiple Sclerosis: A Trans-regional Digital Health E NCT07280871	Luxembourg Institute of Health	—
Recruiting	Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis NCT05964829	Cionic, Inc.	N/A
Recruiting	Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy NCT05359653	University of California, San Francisco	Phase 1 / Phase 2
Unknown	Transient and Immediate Motor Effects of Exercise in Progressive Multiple Sclerosis NCT05562414	Klinik Valens	N/A
Unknown	MUSCLE - Nordic Walking in MUltiple SCLErosis NCT05385731	Leonardo A. Peyré-Tartaruga	N/A
Unknown	Exercise Effects in Multiple Sclerosis NCT05496881	University of Regina	N/A
Completed	Safety and Efficacy of Repeated Administration of NurOwn (MSC-NTF Cells) in Participants With Progressive MS NCT03799718	Brainstorm-Cell Therapeutics	Phase 2
Unknown	Sensitivity of Motor Assessment in MS - a Prospective Cohort Study NCT04993274	Friedemann Paul	—
Completed	Follow-up Study of the Effectiveness of Virtual Reality Therapy in MS Patients NCT04550650	Somogy Megyei Kaposi Mór Teaching Hospital	N/A
Completed	The Effect of Neurorehabilitation Therapy on Postural Control, Mobility and Quality of Life in Multiple Sclero NCT03424538	Somogy Megyei Kaposi Mór Teaching Hospital	N/A
Unknown	Tolerogenic Dendritic Cells as a Therapeutic Strategy for the Treatment of Multiple Sclerosis Patients (TOLERV NCT02903537	Fundació Institut Germans Trias i Pujol	Phase 1
Unknown	Evidence Based Patient Information and Smartphone Accelerometry to Enhance Physical Activity in MS NCT03114293	Universitätsklinikum Hamburg-Eppendorf	N/A
Completed	Intrathecal Rituximab in Progressive Multiple Sclerosis NCT02545959	Centre Hospitalier de PAU	Phase 2
Completed	Rotating Frame Relaxation Imaging in Patients With Multiple Sclerosis NCT02403570	Turku University Hospital	—
Completed	China Betaferon Adherence, Coping and Nurse Support Study NCT01436838	Bayer	—
Completed	Lipoic Acid for Secondary Progressive Multiple Sclerosis (MS) NCT01188811	VA Office of Research and Development	Phase 2 / Phase 3
Unknown	Safety Study of RTL1000 (Recombinant T Cell Receptor Ligand) in Subjects With Multiple Sclerosis NCT00411723	Artielle ImmunoTherapeutics	Phase 1
Completed	Efficacy of Cyclophosphamide Versus Methylprednisolone in Patients With Secondary Progressive Multiple Scleros NCT00241254	University Hospital, Bordeaux	Phase 3
Unknown	Evaluation of Efficiency of Ritalin in Multiple Sclerosis (MS) Patients NCT00220493	Sheba Medical Center	Phase 1